SE0000773D0 - New formulation - Google Patents

New formulation

Info

Publication number
SE0000773D0
SE0000773D0 SE0000773A SE0000773A SE0000773D0 SE 0000773 D0 SE0000773 D0 SE 0000773D0 SE 0000773 A SE0000773 A SE 0000773A SE 0000773 A SE0000773 A SE 0000773A SE 0000773 D0 SE0000773 D0 SE 0000773D0
Authority
SE
Sweden
Prior art keywords
pharmaceutical composition
proton pump
pump inhibitor
optionally
combination
Prior art date
Application number
SE0000773A
Other languages
English (en)
Swedish (sv)
Inventor
Christina Holmberg
Britta Siekmann
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Priority to SE0000773A priority Critical patent/SE0000773D0/xx
Publication of SE0000773D0 publication Critical patent/SE0000773D0/xx
Priority to ARP010100865A priority patent/AR027555A1/es
Priority to SK1257-2002A priority patent/SK285982B6/sk
Priority to CN201010156308A priority patent/CN101862453A/zh
Priority to CN018061613A priority patent/CN1416335B/zh
Priority to JP2001564741A priority patent/JP4663197B2/ja
Priority to BR0109014-3A priority patent/BR0109014A/pt
Priority to ES01910305T priority patent/ES2220728T3/es
Priority to AU2001237876A priority patent/AU2001237876B2/en
Priority to MXPA02008657A priority patent/MXPA02008657A/es
Priority to PL358595A priority patent/PL202683B1/pl
Priority to NZ521009A priority patent/NZ521009A/en
Priority to AU3787601A priority patent/AU3787601A/xx
Priority to US10/220,791 priority patent/US20030161846A1/en
Priority to AT01910305T priority patent/ATE268162T1/de
Priority to DK01910305T priority patent/DK1267832T3/da
Priority to RU2002122744/15A priority patent/RU2270675C9/ru
Priority to KR1020027011731A priority patent/KR100771317B1/ko
Priority to SI200130137T priority patent/SI1267832T1/xx
Priority to TR2004/01906T priority patent/TR200401906T4/
Priority to CZ20023005A priority patent/CZ20023005A3/cs
Priority to IL15142701A priority patent/IL151427A0/xx
Priority to EP01910305A priority patent/EP1267832B1/en
Priority to HU0300882A priority patent/HUP0300882A3/hu
Priority to PCT/SE2001/000467 priority patent/WO2001066088A1/en
Priority to CA2401498A priority patent/CA2401498C/en
Priority to PT01910305T priority patent/PT1267832E/pt
Priority to DE60103627T priority patent/DE60103627T2/de
Priority to EEP200200500A priority patent/EE200200500A/xx
Priority to UA2002086883A priority patent/UA82979C2/ru
Priority to MYPI20011045A priority patent/MY127237A/en
Priority to ZA200206740A priority patent/ZA200206740B/en
Priority to IS6539A priority patent/IS6539A/is
Priority to NO20024272A priority patent/NO20024272L/no
Priority to HK03102781A priority patent/HK1050632A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
SE0000773A 2000-03-08 2000-03-08 New formulation SE0000773D0 (sv)

Priority Applications (35)

Application Number Priority Date Filing Date Title
SE0000773A SE0000773D0 (sv) 2000-03-08 2000-03-08 New formulation
ARP010100865A AR027555A1 (es) 2000-03-08 2001-02-26 Nuevo sistema de administracion de farmacos emulsionante
UA2002086883A UA82979C2 (ru) 2000-03-08 2001-03-06 Фармацевтическая композиция, пригодная для перорального введения, которая содержит no-высвобождающие нспвл, лекарственная форма, фармацевтическая комбинация и способы лечения
RU2002122744/15A RU2270675C9 (ru) 2000-03-08 2001-03-06 Новая самоэмульгирующаяся система доставки лекарств
TR2004/01906T TR200401906T4 (tr) 2000-03-08 2001-03-06 Kendini emülsifiye ilaç sistemi, yağ ajanı seçime bağlıdır.
CN018061613A CN1416335B (zh) 2000-03-08 2001-03-06 新的自乳化药物释放体系
JP2001564741A JP4663197B2 (ja) 2000-03-08 2001-03-06 新規な自己乳化性薬物送達系
BR0109014-3A BR0109014A (pt) 2000-03-08 2001-03-06 Composição farmacêutica, forma de dosagem unitária, solução oral, kit, e, método para o tratamento da dor e de inflamações
ES01910305T ES2220728T3 (es) 2000-03-08 2001-03-06 Sistema de suministro de un farmaco autoemulsionante, en el que el agente graso es opcional.
AU2001237876A AU2001237876B2 (en) 2000-03-08 2001-03-06 New self emulsifying drug delivery system
MXPA02008657A MXPA02008657A (es) 2000-03-08 2001-03-06 Nuevo sistema de suministro de farmacos auto-emulsionante..
PL358595A PL202683B1 (pl) 2000-03-08 2001-03-06 Kompozycja farmaceutyczna w postaci prekoncentratu emulsji, jednostkowa postać dawkowana, zestaw i zastosowanie kompozycji farmaceutycznej
NZ521009A NZ521009A (en) 2000-03-08 2001-03-06 Emulsion preconcentrate containing a nitric ester non-steroid anti-inflammatory agent and a surfactant that forms an emulsion on contact with aqueous media
AU3787601A AU3787601A (en) 2000-03-08 2001-03-06 New self emulsifying drug delivery system
US10/220,791 US20030161846A1 (en) 2000-03-08 2001-03-06 Self emulsifying drug delivery system
AT01910305T ATE268162T1 (de) 2000-03-08 2001-03-06 Selbstemulgierendes arzneistoffverabreichungssystem, wobei das fettmittel optional ist
DK01910305T DK1267832T3 (da) 2000-03-08 2001-03-06 Selvemulgerende lægemiddelafgivelsessystem, hvor fedtstoffet er valgfrit
SK1257-2002A SK285982B6 (sk) 2000-03-08 2001-03-06 Farmaceutická kompozícia na orálne podávanie, jednotková dávková forma a kit s jej obsahom a jej použitie
KR1020027011731A KR100771317B1 (ko) 2000-03-08 2001-03-06 신규한 자가-에멀젼화 약물 전달 시스템
SI200130137T SI1267832T1 (en) 2000-03-08 2001-03-06 SELF EMULSIFYING DRUG DELIVERY SYSTEM, wherein the fatty agent is optional
CN201010156308A CN101862453A (zh) 2000-03-08 2001-03-06 新的自乳化药物释放体系
CZ20023005A CZ20023005A3 (cs) 2000-03-08 2001-03-06 Nový samoemulgační systém pro podávání léčiva
IL15142701A IL151427A0 (en) 2000-03-08 2001-03-06 New self emulsifying drug delivery system
EP01910305A EP1267832B1 (en) 2000-03-08 2001-03-06 SELF EMULSIFYING DRUG DELIVERY SYSTEM, wherein the fatty agent is optional
HU0300882A HUP0300882A3 (en) 2000-03-08 2001-03-06 New self emulsifying drug delivery system
PCT/SE2001/000467 WO2001066088A1 (en) 2000-03-08 2001-03-06 New self emulsifying drug delivery system
CA2401498A CA2401498C (en) 2000-03-08 2001-03-06 New self emulsifying drug delivery system
PT01910305T PT1267832E (pt) 2000-03-08 2001-03-06 Sistema auto-emulsionante de libertacao de farmaco
DE60103627T DE60103627T2 (de) 2000-03-08 2001-03-06 SELBSTEMULGIERENDES ARZNEISTOFFVERABREICHUNGSSYSTEM, wobei das Fettmittel optional ist
EEP200200500A EE200200500A (et) 2000-03-08 2001-03-06 Uus iseemulgeeruv ravimi manustamise süsteem
MYPI20011045A MY127237A (en) 2000-03-08 2001-03-07 New self emulsifying drug delivery system
ZA200206740A ZA200206740B (en) 2000-03-08 2002-08-22 New self emulsifying drug delivery system.
IS6539A IS6539A (is) 2000-03-08 2002-09-03 Nýtt sjálfgert dropakerfi fyrir lyfjagjöf
NO20024272A NO20024272L (no) 2000-03-08 2002-09-06 Nytt selvemulgerende legemiddelavleveringssystem
HK03102781A HK1050632A1 (en) 2000-03-08 2003-04-16 Self emulsifying drug delivery system, wherein thefatty agent is optional.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0000773A SE0000773D0 (sv) 2000-03-08 2000-03-08 New formulation

Publications (1)

Publication Number Publication Date
SE0000773D0 true SE0000773D0 (sv) 2000-03-08

Family

ID=20278739

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0000773A SE0000773D0 (sv) 2000-03-08 2000-03-08 New formulation

Country Status (31)

Country Link
US (1) US20030161846A1 (es)
EP (1) EP1267832B1 (es)
JP (1) JP4663197B2 (es)
KR (1) KR100771317B1 (es)
CN (2) CN101862453A (es)
AT (1) ATE268162T1 (es)
AU (2) AU3787601A (es)
BR (1) BR0109014A (es)
CA (1) CA2401498C (es)
CZ (1) CZ20023005A3 (es)
DE (1) DE60103627T2 (es)
DK (1) DK1267832T3 (es)
EE (1) EE200200500A (es)
ES (1) ES2220728T3 (es)
HK (1) HK1050632A1 (es)
HU (1) HUP0300882A3 (es)
IL (1) IL151427A0 (es)
IS (1) IS6539A (es)
MX (1) MXPA02008657A (es)
MY (1) MY127237A (es)
NO (1) NO20024272L (es)
NZ (1) NZ521009A (es)
PL (1) PL202683B1 (es)
PT (1) PT1267832E (es)
RU (1) RU2270675C9 (es)
SE (1) SE0000773D0 (es)
SK (1) SK285982B6 (es)
TR (1) TR200401906T4 (es)
UA (1) UA82979C2 (es)
WO (1) WO2001066088A1 (es)
ZA (1) ZA200206740B (es)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6852739B1 (en) 1999-02-26 2005-02-08 Nitromed Inc. Methods using proton pump inhibitors and nitric oxide donors
SE0000774D0 (sv) 2000-03-08 2000-03-08 Astrazeneca Ab New formulation
IT1319202B1 (it) 2000-10-12 2003-09-26 Nicox Sa Farmaci per le malattie a base infiammatoria.
US8206741B2 (en) 2001-06-01 2012-06-26 Pozen Inc. Pharmaceutical compositions for the coordinated delivery of NSAIDs
SE0102993D0 (sv) * 2001-09-07 2001-09-07 Astrazeneca Ab New self emulsifying drug delivery system
SE0200895D0 (sv) * 2002-03-22 2002-03-22 Astrazeneca Ab New pharmaceutical composition
FR2838349B1 (fr) * 2002-04-15 2004-06-25 Laurence Paris Compositions liquides pour capsules molle a liberation prolongee et leur procede de fabrication
ITMI20021392A1 (it) * 2002-06-25 2003-12-29 Nicox Sa Forme farmaceutiche per la somministrazione orale di farmaci liquidi a temperatura ambiente dotate di migliore biodisponibilita'
US7163958B2 (en) 2002-07-03 2007-01-16 Nitromed Inc. Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use
US7244753B2 (en) 2002-07-29 2007-07-17 Nitromed, Inc. Cyclooxygenase-2 selective inhibitors, compositions and methods of use
AU2003254282A1 (en) 2002-08-01 2004-02-23 Nitromed, Inc. Nitrosated proton pump inhibitors, compositions and methods of use
FR2845917B1 (fr) * 2002-10-21 2006-07-07 Negma Gild Composition pharmaceutique associant le tenatoprazole et un anti-inflammatoire
SE0301880D0 (sv) * 2003-06-25 2003-06-25 Astrazeneca Uk Ltd New drug delivery composition
KR20050034299A (ko) * 2003-10-09 2005-04-14 한국유나이티드제약 주식회사 아세클로페낙 자가유화에멀젼 및 이를 이용한 연질캅셀제조성물 및 그의 제조방법
NZ564589A (en) 2005-07-26 2010-01-29 Nicox Sa Pharmaceutical formulation of nitrooxyderivatives of NSAIDs
US20070154542A1 (en) * 2005-12-30 2007-07-05 Cogentus Pharmaceuticals, Inc. Oral pharmaceutical formulations containing non-steroidal anti-inflammatory drugs and acid inhibitors
AU2009290712A1 (en) 2008-09-09 2010-03-18 Astrazeneca Ab Method for delivering a pharmaceutical composition to patient in need thereof
DK2367542T3 (da) * 2008-12-03 2014-03-10 Astellas Deutschland Gmbh Orale doseringsformer af bendamustin
US20100273730A1 (en) * 2009-04-27 2010-10-28 Innopharmax, Inc. Self-emulsifying pharmaceutical compositions of hydrophilic drugs and preparation thereof
CA2764963C (en) 2009-06-25 2016-11-01 Astrazeneca Ab Method for treating a patient at risk for developing an nsaid-associated ulcer
GEP20146016B (en) * 2009-07-07 2014-01-27 Boehringer Ingelheim Int Pharmaceutical composition containing hepatitis c viral protease inhibitor
EP2488022B1 (en) 2009-10-16 2018-01-10 Mochida Pharmaceutical Co., Ltd. Compositions
UA115139C2 (uk) 2011-12-28 2017-09-25 Поузен Інк. Спосіб доставки фармацевтичної композиції, яка містить омепразол й ацетилсаліцилову кислоту, пацієнту
CN102614115B (zh) * 2012-04-26 2013-05-15 河南中医学院 一种双氯芬酸钠自乳化软膏
ES2957541T3 (es) 2013-08-27 2024-01-22 Vasilios Voudouris Composiciones farmacéuticas de bendamustina
WO2016117057A1 (ja) * 2015-01-21 2016-07-28 持田製薬株式会社 ω３脂肪酸の自己乳化組成物
JP6989489B2 (ja) * 2015-08-07 2022-01-05 インファースト ヘルスケア リミテッド Ｎｓａｉｄのための固溶体組成物
CN113440481B (zh) * 2021-08-13 2022-06-14 湖南慧泽生物医药科技有限公司 伊布替尼的自微乳组合物

Family Cites Families (60)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE7804231L (sv) * 1978-04-14 1979-10-15 Haessle Ab Magsyrasekretionsmedel
JPS59227870A (ja) * 1983-06-07 1984-12-21 Yamanouchi Pharmaceut Co Ltd 新規２−グアニジノチアゾリン誘導体ならびにその製造法
US4554276A (en) * 1983-10-03 1985-11-19 Pfizer Inc. 2-Amino-5-hydroxy-4-methylpyrimidine derivatives
US4552899A (en) * 1984-04-09 1985-11-12 Analgesic Associates Cough/cold mixtures comprising non-steroidal anti-inflammatory drugs
IL75400A (en) * 1984-06-16 1988-10-31 Byk Gulden Lomberg Chem Fab Dialkoxypyridine methyl(sulfinyl or sulfonyl)benzimidazoles,processes for the preparation thereof and pharmaceutical compositions containing the same
US4766117A (en) * 1984-10-11 1988-08-23 Pfizer Inc. Antiinflammatory compositions and methods
US4704278A (en) * 1984-10-17 1987-11-03 American Home Products Corp (Del) Fluidized magaldrate suspension
US4676984A (en) * 1985-08-14 1987-06-30 American Home Products Corp. Rehydratable antacid composition
US4965065A (en) * 1986-04-29 1990-10-23 Bristol-Myers Squibb Company Gastroprotective process and compositions
US4757060A (en) * 1986-03-04 1988-07-12 Bristol-Myers Company Non-steroidal anti-inflammatory compositions protected against gastrointestinal injury with a combination of certain H1 and H2, receptor blockers
US5037815A (en) * 1986-03-04 1991-08-06 Bristol-Myers Squibb Co. Non-steroidal anti-inflammatory compositions protected against gastrointestinal injury with a combination of certain H1 - and H2 -receptor blockers
US5043358A (en) * 1986-03-04 1991-08-27 Bristol-Myers Squibb Company Gastroprotective process
GB2189698A (en) * 1986-04-30 1987-11-04 Haessle Ab Coated omeprazole tablets
US5260333A (en) * 1986-08-08 1993-11-09 Bristol Myers Squibb Company Effect of a combination of a terbutaline, diphenhydramine and ranitidine composition on gastrointestinal injury produced by nonsteroidal anti-inflammatory compositions
US5204118A (en) * 1989-11-02 1993-04-20 Mcneil-Ppc, Inc. Pharmaceutical compositions and methods for treating the symptoms of overindulgence
AU1252692A (en) * 1991-03-04 1992-10-06 Warner-Lambert Company Novel salts/ion pairs of non-steroidal anti-inflammatory drugs in various dosage forms
ES2130152T3 (es) * 1991-12-06 1999-07-01 Glaxo Group Ltd Medicamentos para tratar dolencias inflamatorias o para analgesia que contienen un nsaid y ranitidina/citrato de bismuto.
US5294433A (en) * 1992-04-15 1994-03-15 The Procter & Gamble Company Use of H-2 antagonists for treatment of gingivitis
IT1256345B (it) * 1992-08-20 1995-12-01 Esteri nitrici di derivati dell'acido 2-(2,6-di-alo-fenilammino) fenilacetico e procedimento per la loro preparazione
IT1256450B (it) * 1992-11-26 1995-12-05 Soldato Piero Del Esteri nitrici con attivita' farmacologica e procedimento per la loro preparazione
US5686105A (en) * 1993-10-19 1997-11-11 The Procter & Gamble Company Pharmaceutical dosage form with multiple enteric polymer coatings for colonic delivery
CH686761A5 (de) * 1993-05-27 1996-06-28 Sandoz Ag Galenische Formulierungen.
DK66493D0 (da) * 1993-06-08 1993-06-08 Ferring A S Praeparater, isaer til brug ved behandling af inflammatoriske tarmsygdomme eller til at opnaa forbedret saarheling
FR2710535B1 (fr) * 1993-09-30 1995-11-24 Gattefosse Ets Sa Composition à usage pharmaceutique ou cosmétique apte à former une microémulsion.
US6312704B1 (en) * 1993-09-30 2001-11-06 Gattefosse, S.A. Orally administrable composition capable of providing enhanced bioavailability when ingested
US6054136A (en) * 1993-09-30 2000-04-25 Gattefosse S.A. Orally administrable composition capable of providing enhanced bioavailability when ingested
JP3775796B2 (ja) * 1993-10-06 2006-05-17 ニコックス エス エイ 抗炎症活性及び／又は鎮痛活性を有する硝酸エステル類及びそれらの製造方法
US5514663A (en) * 1993-10-19 1996-05-07 The Procter & Gamble Company Senna dosage form
WO1995011024A1 (en) * 1993-10-19 1995-04-27 The Procter & Gamble Company Picosulphate dosage form
US6025395A (en) * 1994-04-15 2000-02-15 Duke University Method of preventing or delaying the onset and progression of Alzheimer's disease and related disorders
US5643960A (en) * 1994-04-15 1997-07-01 Duke University Method of delaying onset of alzheimer's disease symptoms
AU702662B2 (en) * 1994-05-10 1999-02-25 Nicox S.A. Nitro compounds and their compositions having anti-inflammatory, analgesic and anti-thrombotic acitivities
SE9500478D0 (sv) * 1995-02-09 1995-02-09 Astra Ab New pharmaceutical formulation and process
US5955451A (en) * 1995-05-12 1999-09-21 The University Of Texas System Board Of Regents Methods of enhancing the therapeutic activity of NSAIDS and compositions of zwitterionic phospholipids useful therein
EP0760237A1 (en) * 1995-08-30 1997-03-05 Cipla Limited Oil-in-water microemulsions
SE9600070D0 (sv) * 1996-01-08 1996-01-08 Astra Ab New oral pharmaceutical dosage forms
US6231888B1 (en) * 1996-01-18 2001-05-15 Perio Products Ltd. Local delivery of non steroidal anti inflammatory drugs (NSAIDS) to the colon as a treatment for colonic polyps
US6160020A (en) * 1996-12-20 2000-12-12 Mcneill-Ppc, Inc. Alkali metal and alkaline-earth metal salts of acetaminophen
SE510666C2 (sv) * 1996-12-20 1999-06-14 Astra Ab Nya Kristallmodifikationer
SE510643C2 (sv) * 1997-06-27 1999-06-14 Astra Ab Termodynamiskt stabil omeprazol natrium form B
KR100509131B1 (ko) * 1997-07-29 2005-08-18 파마시아 앤드 업존 캄파니 엘엘씨 산성 친지성 화합물의, 자가유화 제제 형태의 제약 조성물
JP2001521910A (ja) * 1997-10-31 2001-11-13 モンサント カンパニー ゲランガム錠剤コーティング
EP1056457A4 (en) * 1998-01-30 2006-10-25 Sepracor Inc S-LANSOPRAZOLE COMPOSITIONS AND METHODS OF USE
CA2320963A1 (en) * 1998-01-30 1999-08-05 Sepracor, Inc. R-lansoprazole compositions and methods
AU3843999A (en) * 1998-05-07 1999-11-23 Elan Corporation, Plc Solvent/cosolvent free microemulsion and emulsion preconcentrate drug delivery systems
EP0984012A3 (en) * 1998-08-31 2001-01-10 Pfizer Products Inc. Nitric oxide releasing oxindole prodrugs with analgesic and anti-inflammatory properties
KR100695562B1 (ko) * 1998-09-28 2007-03-15 워너-램버트 캄파니 엘엘씨 Ｈｐｍｃ 캡슐을 이용한 장 및 결장에의 전달방법
US6485747B1 (en) * 1998-10-30 2002-11-26 Monsanto Company Coated active tablet(s)
MXPA01005884A (es) * 1998-12-11 2002-04-24 Pharmasolutions Inc Composiciones auto-emulsionantes para medicamentos escasamente solubles en agua.
US6635281B2 (en) * 1998-12-23 2003-10-21 Alza Corporation Gastric retaining oral liquid dosage form
US6267985B1 (en) * 1999-06-30 2001-07-31 Lipocine Inc. Clear oil-containing pharmaceutical compositions
US6294192B1 (en) * 1999-02-26 2001-09-25 Lipocine, Inc. Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents
US6126816A (en) * 1999-07-14 2000-10-03 Ruiz, Jr.; Reuben F. Wastewater treatment device
US6787164B2 (en) * 2000-02-23 2004-09-07 Bioselect Innovations, Inc. Composition and method for treating the effects of diseases and maladies
SE0000774D0 (sv) * 2000-03-08 2000-03-08 Astrazeneca Ab New formulation
US20020044962A1 (en) * 2000-06-06 2002-04-18 Cherukuri S. Rao Encapsulation products for controlled or extended release
SE0002476D0 (sv) * 2000-06-30 2000-06-30 Astrazeneca Ab New compounds
US6544556B1 (en) * 2000-09-11 2003-04-08 Andrx Corporation Pharmaceutical formulations containing a non-steroidal antiinflammatory drug and a proton pump inhibitor
US20020045184A1 (en) * 2000-10-02 2002-04-18 Chih-Ming Chen Packaging system
FR2818905A1 (fr) * 2000-12-28 2002-07-05 Cll Pharma Compositions pharmaceutiques colloidales micellaires renfermant un principe actif lipophile

Also Published As

Publication number Publication date
NZ521009A (en) 2004-06-25
JP2003525894A (ja) 2003-09-02
HK1050632A1 (en) 2003-07-04
KR20030011787A (ko) 2003-02-11
NO20024272D0 (no) 2002-09-06
JP4663197B2 (ja) 2011-03-30
RU2270675C2 (ru) 2006-02-27
RU2270675C9 (ru) 2006-06-27
AU3787601A (en) 2001-09-17
CN1416335B (zh) 2010-04-28
US20030161846A1 (en) 2003-08-28
EP1267832A1 (en) 2003-01-02
UA82979C2 (ru) 2008-06-10
PL202683B1 (pl) 2009-07-31
WO2001066088A1 (en) 2001-09-13
SK285982B6 (sk) 2007-12-06
CA2401498C (en) 2010-05-18
DE60103627D1 (de) 2004-07-08
HUP0300882A2 (hu) 2003-09-29
ZA200206740B (en) 2003-11-24
BR0109014A (pt) 2003-06-03
EE200200500A (et) 2004-02-16
IS6539A (is) 2002-09-03
HUP0300882A3 (en) 2005-04-28
CN101862453A (zh) 2010-10-20
IL151427A0 (en) 2003-04-10
RU2002122744A (ru) 2004-03-20
PL358595A1 (en) 2004-08-09
MY127237A (en) 2006-11-30
CN1416335A (zh) 2003-05-07
ATE268162T1 (de) 2004-06-15
ES2220728T3 (es) 2004-12-16
DK1267832T3 (da) 2004-08-30
DE60103627T2 (de) 2005-06-16
NO20024272L (no) 2002-11-05
SK12572002A3 (sk) 2003-05-02
PT1267832E (pt) 2004-09-30
CZ20023005A3 (cs) 2003-02-12
AU2001237876B2 (en) 2005-02-17
TR200401906T4 (tr) 2004-09-21
MXPA02008657A (es) 2003-02-24
EP1267832B1 (en) 2004-06-02
CA2401498A1 (en) 2001-09-13
KR100771317B1 (ko) 2007-10-29

Similar Documents

Publication Publication Date Title
SE0000773D0 (sv) New formulation
SE0000774D0 (sv) New formulation
SE0102993D0 (sv) New self emulsifying drug delivery system
BR0107535A (pt) Uso de carotenóides e forma de dosagem unitária destes
IS4397A (is) Ný lyfjablanda til meðhöndlunar á verkjum sem inniheldur staðdeyfiefni, skautuð lípíð og tríasýlglýseról
DK0715856T3 (da) Antifungalt præparat som kan oplagres i keratinlaget, til ekstern anvendelse
UY27296A1 (es) Composición farmacéutica que contiene mosaprida y pancreatina
NO20011217D0 (no) Doseringsform omfattende væskeformulering
BR0108738A (pt) Formulações anestésicas
NZ522242A (en) Use of 13-hode as a regulator of vascular biocompatibility and an inhibitor of cell hyperplasia
PT1249231E (pt) Formulacoes farmaceuticas contendo substancias activas anti-inflamatorias e sua utilizacao
IT1291895B1 (it) Preparazione farmaceutica fluida a base di nimesulide per uso orale e rinofaringeo
AR027555A1 (es) Nuevo sistema de administracion de farmacos emulsionante
KR970005289A (ko) 디프사쿠스 사포닌 C(Dipsacus saponin C)를 유효성분으로 함유하는 비마약성 중추성 진통제
ECSP982720A (es) Formulacion que contiene un opioide en combinacion con un agonista adrenergico y su utilizacion como analgesico
SV2003000456A (es) Emulsiones estables para productos cosmeticos
AR025498A1 (es) Una nueva asociacion farmaceutica que presenta un efecto analgesico
AR030964A1 (es) Una formulacion farmaceutica con una matriz que forma un gel hidrofilico, formulacion que comprende una o mas sustancias activas, y metodo para preparar tal formulacion que tiene una liberacion prolongada sustancialmente independiente de la fuerza ionica